INS and endometrial cancer: Our findings that a genetically predicted increase in FI raises endometrial cancer risk, while a genetically predicted increase in postchallenge insulin levels (not associated with insulin resistance (10) or with FI [Figure 3]) also raises endometrial cancer risk, jointly support a causal role for hyperinsulinemia in the etiology of endometrial cancer.